Aspirin vs clopidogrel in chronic coronary syndromes: a meta-analysis of ethnic differences

Heart, Artery and Coronary DiseasesTherapy and Intervention

Optimal timing of aspirin discontinuation after acute coronary syndrome treated with percutaneous coronary intervention: a systematic review and meta-analysis

Heart

Bujak K, Laudani C, Rinaldi R, Łajczak P, Gąsior M, Pawlas N, Ortega-Paz L, Sabate M, Brugaletta S

doi: 10.1136/heartjnl-2026-328334

Heart, Artery and Coronary Diseases

Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis

Lancet

Valgimigli M, Choi KH, Giacoppo D, Gragnano F, Kimura T, Watanabe H, Kim HS, Kang J, Park KW, Pettersen AÅ, Woodward M, Bhatt DL, Calabrò P, Angiolillo DJ, Mehran R, Song YB, Hahn JY

doi: 10.1016/S0140-6736(25)01562-4

Heart, Artery and Coronary DiseasesTherapy and Intervention

Oral Anticoagulation With or Without Antiplatelet Therapy in Chronic Coronary Syndrome: A Meta-Analysis of Randomized Trials

JACC Cardiovasc Interv

Galli M, Vinciguerra M, Laudani C, Occhipinti G, D'Amario D, Iaconelli A, Franchi F, Greco E, Frati G, Sciarretta S, Capodanno D, Gorog DA, Lopes RD, Gibson CM, Mehran R, Angiolillo DJ

doi: 10.1016/j.jcin.2026.03.020

Cardiovascular Risk and Diseases

The prognostic value of systemic inflammatory response index (SIRI) in acute coronary syndrome patients treated with primary percutaneous coronary intervention: a meta-analysis and systematic review

Clin Res Cardiol

Hu C, Ye Q, You S, Li S, Dostal C, Ernst M, Paneni F, Pokreisz P, Szabo GT, Kiss A, Podesser BK

doi: 10.1007/s00392-026-02889-4

Heart, Artery and Coronary Diseases

Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention: 10-year follow-up of the HOST-EXAM trial

Lancet

Kang J, Park S, Yang HM, Shin ES, Rha SW, Bae JW, Lee NH, Yoon HJ, Cho YH, Kim U, Kim SY, Kim SH, Han JK, Park KW, Kim HS, HOST-EXAM investigators

doi: 10.1016/S0140-6736(26)00422-8

Heart, Artery and Coronary Diseases

Fractional flow reserve vs angiography to guide percutaneous coronary intervention: an individual patient data meta-analysis

Eur Heart J

Mangiacapra F, Paolucci L, De Bruyne B, Rioufol G, Hahn JY, Chen SL, Koo BK, Tonino PAL, van 't Veer M, Motreff P, Angoulvant D, Lee JM, Hwang D, Yang S, Pijls NHJ, Barbato E, Physiology and Revascularization for Myocardial Endpoints (PRIME) Collaboration

doi: 10.1093/eurheartj/ehaf504

Heart, Artery and Coronary Diseases

Efficacy and Safety of Prasugrel, Ticagrelor, or Clopidogrel After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

JAMA Cardiol

Maqsood MH, Feit F, Kaul U, Rao SV, Giacoppo D, Kastrati A, Bangalore S

doi: 10.1001/jamacardio.2026.1128

Cardiovascular Risk and Diseases

Antiplatelet therapy with clopidogrel versus aspirin in atherosclerotic cardiovascular disease: a systematic review and meta-analysis

Atherosclerosis

Tscharre M, Mutschlechner D, Huber K, Gremmel T

doi: 10.1016/j.atherosclerosis.2025.120478

Heart, Artery and Coronary Diseases

Aspirin dosing after acute coronary syndrome with suspected aspirin resistance: the ANDAMAN trial

Eur Heart J

Dillinger JG, Pezel T, Batias L, Angoulvant D, Goralski M, Ferrari E, Cayla G, Silvain J, Gilard M, Lemesle G, Souteyrand G, Lim P, Roubille F, Georges JL, Bal Dit Sollier C, Petroni T, Morel O, Delarche N, Elbaz M, Puymirat E, Toupin S, Montalescot G, Drouet L, Vicaut E, Henry P, ANDAMAN Investigators of the ACTION Study Group

doi: 10.1093/eurheartj/ehaf680

Related content

Optimal timing of aspirin discontinuation after acute coronary syndrome treated with percutaneous coronary intervention: a systematic review and meta-analysis

Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis

Oral Anticoagulation With or Without Antiplatelet Therapy in Chronic Coronary Syndrome: A Meta-Analysis of Randomized Trials

The prognostic value of systemic inflammatory response index (SIRI) in acute coronary syndrome patients treated with primary percutaneous coronary intervention: a meta-analysis and systematic review

Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention: 10-year follow-up of the HOST-EXAM trial

Fractional flow reserve vs angiography to guide percutaneous coronary intervention: an individual patient data meta-analysis

Efficacy and Safety of Prasugrel, Ticagrelor, or Clopidogrel After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

Antiplatelet therapy with clopidogrel versus aspirin in atherosclerotic cardiovascular disease: a systematic review and meta-analysis

Aspirin dosing after acute coronary syndrome with suspected aspirin resistance: the ANDAMAN trial